Order Article Reprints

Švec J, Šťastná M, Janečková L, Hrčkulák D, Vojtěchová M, Onhajzer J, Kříž V, Galušková K, Šloncová E, Kubovčiak J, et al. TROP2 Represents a Negative Prognostic Factor in Colorectal Adenocarcinoma and Its Expression Is Associated with Features of Epithelial–Mesenchymal Transition and Invasiveness. Cancers. 2022; 14(17):4137. https://doi.org/10.3390/cancers14174137

Švec, Jiří, Monika Šťastná, Lucie Janečková, Dušan Hrčkulák, Martina Vojtěchová, Jakub Onhajzer, Vítězslav Kříž, Kateřina Galušková, Eva Šloncová, Jan Kubovčiak, and et al. 2022. "TROP2 Represents a Negative Prognostic Factor in Colorectal Adenocarcinoma and Its Expression Is Associated with Features of Epithelial–Mesenchymal Transition and Invasiveness" Cancers 14, no. 17: 4137. https://doi.org/10.3390/cancers14174137

Švec, J., Šťastná, M., Janečková, L., Hrčkulák, D., Vojtěchová, M., Onhajzer, J., Kříž, V., Galušková, K., Šloncová, E., Kubovčiak, J., Pfeiferová, L., Hrudka, J., Matěj, R., Waldauf, P., Havlůj, L., Kolář, M., & Kořínek, V. (2022). TROP2 Represents a Negative Prognostic Factor in Colorectal Adenocarcinoma and Its Expression Is Associated with Features of Epithelial–Mesenchymal Transition and Invasiveness. Cancers, 14(17), 4137. https://doi.org/10.3390/cancers14174137